# How many people will die from the new Ebola outbreak before 2026? (QID: 39235)

- Type: numeric

- URL: https://www.metaculus.com/questions/39235/

- Classifier: health | strategic=False (score=0.00)

### SeenGuard

- enabled=True | lock_status=acquired

- run_filter: before=20 | skipped=0 | after=20

- debug_note=lock acquired

## Research (summary)

CALIBRATION GUIDANCE (auto-generated weekly):
BINARY CALIBRATION
- No resolved binary questions (with pre-resolution forecasts) yet.
- Advice: keep using base rates + small evidence-weighted updates; avoid big swings.

MULTIPLE-CHOICE CALIBRATION (Top-1)
- No resolved MCQ questions (with pre-resolution forecasts) yet.

NUMERIC CALIBRATION (PIT-lite + CRPS)
- No resolved numeric questions (with pre-resolution forecasts) yet.
- When numeric results exist, we’ll check p10/p50/p90 coverage and CRPS.

General takeaway: apply **small** nudges only where gaps are consistent with decent sample sizes (≥10).
— end calibration —

### Reference class & base rates
1.  **Ebola Outbreaks in the Post-Vaccine Era (since 2019):** This is the most relevant reference class. The approval and stockpiling of the Ervebo (rVSV-ZEBOV) vaccine fundamentally changed outbreak response. There have been approximately 7-8 outbreaks of the Zaire ebolavirus strain since 2019, primarily in the DRC.
    *   **Base Rate:** These outbreaks have been contained relatively quickly. The median number of deaths is low, around **5-15 deaths**. The 2022 Uganda outbreak (142 deaths) is a notable exception as it was the Sudan ebolavirus strain, for which Ervebo is not effective. Excluding that outlier, the range is very tight.
    *   **Reasoning:** This class accounts for the most significant technological and procedural shift in Ebola management. The strategy of "ring vaccination" (vaccinating contacts and contacts-of-contacts) has proven highly effective at halting transmission.
2.  **All Ebola Outbreaks in the DRC (since 1976):** The DRC has the most experience with Ebola, this being its 16th outbreak. This class provides a broader historical context of the country's response capacity.
    *   **Base Rate:** The distribution is highly skewed. The median number of deaths is around **30-50**. However, the mean is much higher due to the catastrophic 2018-2020 Kivu outbreak (~2,280 deaths). Most DRC outbreaks have been contained with fewer than 100 deaths.
    *   **Reasoning:** This class captures country-specific factors like logistical challenges, healthcare infrastructure, and population dynamics, but it mixes pre- and post-vaccine realities, making it less predictive.
3.  **All Ebola Outbreaks (Global, since 1976):** This is the broadest and least useful class, dominated by the 2014-2016 West Africa outbreak (~11,300 deaths).
    *   **Base Rate:** The median is low (~25 deaths), but the mean is in the hundreds, demonstrating a severe fat-tail risk.
    *   **Reasoning:** This class is useful only for illustrating the worst-case potential of Ebola but is not a good prior for a specific outbreak in an experienced country with modern tools.

### Recent developments (timeline bullets)
*   **2025-11-22** ECDC reports no new cases since mid-October and confirms the 42-day countdown to declare the end of the outbreak is underway. — ↓ — Strongest possible signal that the outbreak has been successfully contained and the final death toll is already known.
*   **2025-11-02** ReliefWeb reports the last confirmed patient was discharged on Oct 19, initiating the 42-day countdown. Vaccination has reached ~37,000 people. — ↓ — The discharge of the last known patient is the trigger for the end-of-outbreak protocol. The high vaccination number shows a robust public health response.
*   **2025-11-10** CDC reports a cumulative total of 64 cases and 45 deaths as of Nov 5. — (neutral) — This establishes the current, and likely final, official death toll.
*   **2025-09-04** DRC declares the 16th Ebola outbreak in its history in Kasaï Province. — ↑ — The start of the event, initiating the risk of a large-scale epidemic.

### Mechanisms & drivers (causal levers)
1.  **Public Health Response Speed & Efficacy:** (Large) The speed of detection, contact tracing, and isolation of cases is the primary determinant of an outbreak's size. The DRC's experienced teams, supported by WHO, are a major downward driver.
2.  **Vaccine Availability & Uptake:** (Large) The Ervebo vaccine is highly effective against the Zaire strain. Rapid deployment in a ring vaccination strategy can quickly halt transmission chains. The reported ~37,000 vaccinations is a very strong signal of an effective campaign.
3.  **Geographic Location & Population Density:** (Moderate) Outbreaks in dense, highly mobile urban centers (like Goma in the Kivu outbreak) are far more dangerous than those in remote, rural areas. Kasaï Province is less connected internationally than the eastern provinces, which limits spread.
4.  **Community Trust & Security:** (Moderate) Mistrust of health workers or active conflict can severely hamper response efforts, as seen in the Kivu outbreak. While Kasaï has a history of conflict, the current situation appears stable enough to permit an effective response.
5.  **Virus Strain:** (Large) The outbreak is implicitly the Zaire ebolavirus, as authorities have deployed the Ervebo vaccine. An outbreak of the Sudan strain, for which there was no approved vaccine in 2022, would be a much greater concern.

### Differences vs. the base rate (what’s unusual now)
*   **Mature Response System:** Compared to the average historical outbreak, the DRC's institutional memory and response capacity are at an all-time high after 15 prior outbreaks, including the massive Kivu epidemic.
*   **Effective Vaccine Deployed at Scale:** Unlike pre-2019 outbreaks, a highly effective vaccine is a core part of the response. The vaccination of nearly 37,000 people is a massive intervention that did not exist for most of the reference class period.
*   **Outbreak is Near Official End:** The most unusual feature is that we are forecasting an event whose outcome is almost certain. The 42-day countdown (two full incubation periods) is a standard, reliable WHO protocol. As of Nov 27, the countdown is at day 39, with only 3 days remaining.
*   **Favorable Location:** Unlike the 2018-2020 Kivu outbreak, which occurred in a dense, highly mobile region bordering multiple countries amidst active conflict, the Kasaï outbreak is in a more geographically contained area with fewer complicating security factors.

### Bayesian update sketch (for the statistician)
*   **Prior:** A prior based on the **Post-Vaccine Era reference class** is most appropriate. This suggests a distribution centered low (e.g., a Gamma or Lognormal distribution with a median around 15 deaths) but with a right tail to account for failure risk. An equivalent n of ~10 seems reasonable, reflecting confidence in modern tools but acknowledging uncertainty.
*   **Evidence mapping:**
    *   (↓↓↓) **Last patient discharged and 42-day countdown almost complete:** This is overwhelming evidence. It suggests all known transmission chains have ended.
    *   (↓↓) **No new cases reported since mid-October:** This corroborates the above, indicating containment was successful weeks ago.
    *   (↓) **Extensive vaccination campaign:** Shows that the primary tool for containment was deployed effectively and at scale.
    *   (↑, stale) **Initial growth to 45 deaths:** The outbreak was not trivial and required a significant response. This is the only upward pressure, but it is now historical and has been superseded by containment data.
*   **Net effect:** The evidence provides a massive downward update on any remaining uncertainty. The posterior distribution should collapse almost entirely onto the currently reported number of 45 deaths. The probability of any additional deaths is now extremely low.

### Indicators to watch (leading signals; next weeks/months)
*   **UP indicators:**
    *   Any new confirmed or probable case reported by the DRC MoH or WHO before the 42-day countdown ends (on or around Nov 30, 2025).
    *   Reports of a linked case in a neighboring province or country.
    *   Rumors of community deaths with hemorrhagic symptoms that are being hidden from authorities.
*   **DOWN indicators:**
    *   Official declaration from the DRC Ministry of Health and/or WHO that the outbreak is over (expected around Nov 30/Dec 1, 2025).
    *   Continued reporting of zero new cases in weekly epidemiological bulletins (e.g., from WHO, ECDC).

### Caveats & pitfalls
*   **Reporting Lag:** There is always a small risk of a lag between a case in a remote area and its official reporting.
*   **Hidden Transmission:** A transmission chain could be smoldering undetected in a community that distrusts or is inaccessible to health workers, though this becomes less likely with each passing day.
*   **Flare-up from Survivor:** Ebola virus can persist in the bodily fluids of survivors for months, creating a very small risk of a new transmission chain igniting from a survivor. This is the most plausible, though still very low-probability, risk of a post-countdown case.
*   **Resolution Definition:** The question resolves based on the official count from the DRC Ministère de la Santé. This count is definitive, even if external bodies suspect undercounting. We are forecasting the official number.

**Final Research Summary:** The outbreak appears to be over. The last patient was discharged on October 19, and the 42-day countdown to declare the end of the outbreak will complete around November 30. The final death toll is overwhelmingly likely to be the currently reported number of 45.

Market snapshot debug:
- Metaculus: no open binary results in response
- Manifold: no open binary results in response

### Sources
- Ebola virus disease – Democratic Republic of the Congo (www.who.int) — https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON513
- Ebola Outbreak in the DRC: Current Situation (www.cdc.gov) — https://www.cdc.gov/vhf/ebola/outbreaks/drc/2025-kasai.html
- Communicable disease threats report, week 47, 21-27 November 2025 (www.ecdc.europa.eu) — https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-week-47-2025.pdf
- Democratic Republic of the Congo (DRC), Africa | Ebola - Operation Update #2 (MDRCD047) (reliefweb.int) — https://reliefweb.int/report/democratic-republic-congo/democratic-republic-congo-drc-africa-ebola-operation-update-2-mdrcd047

### Research (debug)

- source=GoogleGrounding | llm=google/gemini-2.5-pro | cached=0 | n_raw=4 | n_kept=4 | cost=$0.024029

- query: Central Africa; Democratic Republic; Kivu Ebola; 2025; 1976; 2020; 2026; 2018; 2019; 2022

### GTMC1 (debug)

- strategic_class=False | strategic_score=0.00 | source=llm

- gtmc1_active=False | qtype=numeric | t_ms=0

- actors_parsed=0

- exceedance_ge_50=None | coalition_rate=None | median=None | dispersion=None

### Ensemble (model outputs)

- OpenRouter-Default: ok=True t_ms=12221 P10=1.000, P50=2019.000, P90=5.000

- Claude-3.7-Sonnet (OR): ok=True t_ms=24835 P10=2025.000, P50=1.000, P90=2019.000

- Gemini: ok=True t_ms=38443 P10=1.000, P50=2019.000, P90=7.000

- Grok: ok=False t_ms=169



### Per-model (raw + usage/cost)

#### OpenRouter-Default

- ok=True | t_ms=12221 | tokens: prompt=3356, completion=589, total=3945 | cost=$0.014280

```md

1. **Base Rate (Prior) Selection**
   - The most appropriate base rate for this forecast is the post-vaccine era Ebola outbreaks, particularly those involving the Zaire ebolavirus strain. Since the approval of the Ervebo vaccine in 2019, outbreaks have been contained more effectively. The median number of deaths in these outbreaks is around 5-15, with a tight distribution excluding outliers like the 2022 Uganda outbreak, which involved a different strain.
   - Mean/Median: ~15 deaths; Variance: Low, given the effectiveness of the vaccine and containment strategies.

2. **Comparison to Base Case**
   - Similarities: The current outbreak involves the Zaire strain, for which the vaccine is effective. The DRC has significant experience managing Ebola outbreaks, and the response has been robust with extensive vaccination.
   - Differences: The outbreak is nearing its official end, with no new cases reported since mid-October, and the last patient discharged on October 19. This suggests a successful containment, which is a positive deviation from the base rate.

3. **Evidence Evaluation (Likelihoods)**
   - No new cases since mid-October and the discharge of the last patient significantly increase the likelihood of the outbreak being contained, suggesting lower final death counts.
   - The extensive vaccination campaign (~37,000 people) further supports containment, reducing the likelihood of additional deaths.
   - The initial growth to 45 deaths indicates the outbreak was not trivial, but this is historical data and less relevant given the containment evidence.

4. **Bayesian Updating (Posterior Distribution)**
   - Prior: Median around 15 deaths, reflecting post-vaccine era containment success.
   - Evidence: The containment evidence (no new cases, last patient discharged, vaccination) strongly suggests the outbreak is over, collapsing the distribution around the current death toll of 45.
   - Posterior: The distribution is now centered around 45 deaths, with very low variance, reflecting the high confidence in containment.

5. **Red Team Thinking**
   - Overconfidence Risk: The main risk is underestimating the potential for hidden transmission or reporting lags. However, the evidence strongly supports containment.
   - Alternative Scenario: A small risk remains of a flare-up from a survivor or hidden transmission, but this is unlikely given the robust response and nearing end of the outbreak.
   - Adjustment: Given the overwhelming evidence of containment, the forecast remains centered around 45 deaths, with minimal tail risk.

6. **Final Percentiles**
   - Given the evidence and analysis, the forecast is tightly centered around the current death toll, with minimal uncertainty.
   - Percentiles reflect the high confidence in the outbreak being contained with no additional deaths.

P10: 45  
P20: 45  
P40: 45  
P60: 45  
P80: 45  
P90: 45

```

#### Claude-3.7-Sonnet (OR)

- ok=True | t_ms=24835 | tokens: prompt=3816, completion=1282, total=5098 | cost=$0.030678

```md

# Forecasting the Death Toll from the 2025 Kasaï Ebola Outbreak

## 1. Base Rate (Prior) Selection

I'll use the **Post-Vaccine Era Ebola Outbreaks (since 2019)** as my primary reference class. This is the most relevant base rate because:

- It accounts for the game-changing Ervebo vaccine approved in 2019
- It reflects modern containment protocols and international response capabilities
- It represents the current technological and procedural reality of Ebola management

This reference class shows:
- Median deaths: ~10-15 per outbreak
- Range: Typically 5-20 deaths, with the 2022 Uganda outbreak (142 deaths) as an outlier
- Distribution shape: Right-skewed, with most outbreaks quickly contained

The 2022 Uganda outbreak is an important outlier because it involved the Sudan strain, for which the Ervebo vaccine is ineffective. For Zaire ebolavirus outbreaks (which this current one appears to be), the post-vaccine containment has been remarkably effective.

## 2. Comparison to Base Case

**Similarities to reference class:**
- This is a Zaire ebolavirus outbreak (implied by vaccine deployment)
- It's occurring in the DRC, a country with extensive Ebola response experience
- Modern international response protocols are in place
- The Ervebo vaccine is available and being deployed

**Key differences:**
- This outbreak has already reached 45 deaths (as of Nov 5, 2025), which is higher than the median post-vaccine outbreak
- The outbreak is already in its final stages with the 42-day countdown nearly complete
- An extensive vaccination campaign has reached ~37,000 people
- The last confirmed patient was discharged on October 19, 2025
- No new cases have been reported since mid-October

These differences strongly suggest that while this outbreak was larger than the typical post-vaccine outbreak, it has been successfully contained and is effectively over.

## 3. Evidence Evaluation (Likelihoods)

**Evidence pushing toward higher death toll:**
- Initial rapid growth to 45 deaths (likelihood ratio ~3:1 favoring above-median outcome)
  - This suggests the outbreak had significant initial momentum before containment

**Evidence pushing toward lower death toll (relative to potential):**
- Last patient discharged on October 19 (likelihood ratio ~100:1 favoring containment)
  - This is the strongest possible signal that transmission chains have ended
- No new cases since mid-October (likelihood ratio ~50:1 favoring containment)
  - Corroborates the above, showing sustained interruption of transmission
- 42-day countdown nearly complete (likelihood ratio ~200:1 favoring no additional deaths)
  - This is the WHO's standard for declaring an outbreak over (two full incubation periods)
- Extensive vaccination campaign reaching ~37,000 people (likelihood ratio ~10:1 favoring containment)
  - Shows robust deployment of the most effective containment tool

The combined evidence overwhelmingly suggests the outbreak has been contained at 45 deaths.

## 4. Bayesian Updating (Posterior Distribution)

Starting with a prior distribution centered around 15 deaths (median of post-vaccine outbreaks) with a right-skewed tail to account for potential larger outbreaks:

**First update - Initial outbreak size:**
- Prior: Median ~15 deaths, 90% CI [5, 100]
- Evidence: Already 45 deaths reported
- Update: Shift distribution upward, new median ~50 deaths, 90% CI [45, 150]
  - This reflects that we've already exceeded the typical post-vaccine outbreak size

**Second update - Containment evidence:**
- Prior: Median ~50 deaths, 90% CI [45, 150]
- Evidence: Last patient discharged, no new cases for >30 days, countdown nearly complete
- Update: Collapse distribution around current value, new median 45 deaths, 90% CI [45, 46]
  - This dramatic narrowing reflects the overwhelming evidence that the outbreak is over

The posterior distribution is now extremely concentrated around 45 deaths, with only a tiny probability mass for values above this.

## 5. Red Team Thinking

**Potential blind spots:**
1. **Unreported cases:** There could be deaths in remote areas not captured in official statistics
   - Counterpoint: The extensive contact tracing and 42-day monitoring period is designed to catch these
   - Adjustment: Slight widening of upper tail to account for this possibility

2. **Survivor reactivation:** Ebola can persist in survivors' bodily fluids for months
   - Counterpoint: Such events are extremely rare and would likely produce only 1-2 additional cases
   - Adjustment: Small probability mass for 46-50 deaths

3. **Reporting lag:** Official death counts might be updated retroactively
   - Counterpoint: At this stage of the outbreak, with intense monitoring, this is unlikely
   - Adjustment: Minimal impact on forecast

4. **Definition precision:** The question resolves to the official count from DRC Ministry of Health
   - This actually reduces uncertainty, as we're forecasting a specific number, not the true toll

After considering these factors, I'll maintain a tight distribution around 45 deaths but allow for a small probability of a few additional deaths before 2026.

## 6. Final Percentiles

P10: 45
P20: 45
P40: 45
P60: 45
P80: 46
P90: 47

```

#### Gemini

- ok=True | t_ms=38443 | tokens: prompt=3625, completion=1300, total=7527 | cost=$0.017531

```md

### 1. Base Rate (Prior) Selection
The most appropriate base rate is the set of **Ebola outbreaks in the post-vaccine era (since 2019)**, specifically for the Zaire ebolavirus strain. The approval and widespread use of the Ervebo (rVSV-ZEBOV) vaccine fundamentally changed Ebola response dynamics. This reference class consists of about 7-8 outbreaks, mostly in the DRC.

*   **Reasoning:** This class controls for the most significant intervention in modern Ebola control: a highly effective vaccine used in a "ring vaccination" strategy. Older reference classes (e.g., all DRC outbreaks, all global outbreaks) are heavily skewed by pre-vaccine events and are less predictive of the outcome of an outbreak where this tool is available and being used.
*   **Distribution:** This reference class has a low median number of deaths, typically around **5-15**. The distribution is right-skewed, but most outbreaks are contained with fewer than 25 deaths. This forms our prior: a belief that the outbreak will likely be small, but with a tail risk of growing larger if containment fails.

### 2. Comparison to Base Case
*   **Similarities:** The current outbreak is in the DRC, a country with more experience fighting Ebola than any other. It involves the Zaire strain, meaning the existing Ervebo vaccine is effective. The response involves experienced local and international teams (DRC MoH, WHO). These factors align well with the post-2019 reference class of small, quickly contained outbreaks.
*   **Differences:** The most critical difference is the **timing and state of the information**. We are not forecasting from the beginning of the outbreak. The provided research report indicates the outbreak is effectively over. The last patient was discharged on October 19, 2025, and a 42-day countdown to declare the end of the outbreak is nearly complete. This is a profound departure from a typical forecasting scenario where the future trajectory is unknown. The outbreak has already exceeded the median of the base rate (45 deaths vs. a median of ~15), but the evidence suggests it has stopped growing.

### 3. Evidence Evaluation (Likelihoods)
The evidence must be evaluated chronologically to understand the updates.

1.  **Initial Outbreak & Growth (Sept 4 - Nov 5):** The outbreak grew to 64 cases and 45 deaths. This evidence would have updated the prior upwards. It showed that this outbreak was more severe than the typical post-vaccine median, suggesting initial transmission was not immediately contained. This would shift the forecast distribution to a median around 45-50, with a significant right tail for potential further escalation.
2.  **Containment Signal (Oct 19 - Nov 22):** The reports from ReliefWeb and the ECDC that the last patient was discharged, no new cases have been seen since mid-October, and the 42-day countdown is underway, constitute overwhelmingly strong evidence in favor of containment. This evidence acts as a massive downward update on the *uncertainty* and the *right tail* of the distribution.
    *   **Likelihood:** This evidence makes a final death toll of 45 extremely likely, and a final toll significantly higher than 45 extremely unlikely. The likelihood function is sharply peaked at the current number of deaths (45).

### 4. Bayesian Updating (Posterior Distribution)
*   **Conceptual Update:**
    *   **Prior:** A distribution centered on ~15 deaths, with a long right tail.
    *   **Likelihood from Growth:** Evidence of growth to 45 deaths shifts the distribution rightward, centering it near 45.
    *   **Likelihood from Containment:** Overwhelming evidence that all transmission chains have been stopped collapses the distribution, eliminating almost all of the right tail and concentrating the probability mass at the current official number.
*   **Posterior Shape:** The posterior distribution is now a very narrow distribution, almost a point mass, at 45 deaths. The median is firmly at 45. The only remaining uncertainty is in the small probability of a few more deaths due to reporting lags or a rare flare-up event.

### 5. Red Team Thinking
*   **Plausible Alternative Scenario:** The primary risk is a "flare-up" caused by a survivor transmitting the virus (e.g., through sexual contact), which can happen months after recovery. This could create a new, small cluster of cases. A second, less likely risk is an undiscovered transmission chain in a remote community that emerges before the end of the year.
*   **Why this might be plausible:** Survivor-based transmission is a known, though rare, phenomenon that has re-ignited past outbreaks. The question's timeframe extends to the end of 2025, leaving a month after the expected declaration for such an event to occur and cause a death.
*   **Rebuttal:** The public health system is on high alert. Any new flare-up would likely be detected and contained very quickly through the same vaccination and contact tracing mechanisms that stopped the main outbreak. Therefore, even if a flare-up occurs, it is unlikely to cause a large number of additional deaths.
*   **Adjustment:** My final distribution must account for this small tail risk. While the most likely outcome is exactly 45 deaths, the upper percentiles (P80, P90) should be slightly higher than 45 to reflect the small but non-zero probability of one or a few more deaths from a flare-up. I will set my P80 at 45, indicating a high degree of confidence (>80%) that the final number will be 45. The P90 will be set at 47 to account for a small cluster of new cases.

### 6. Final Percentiles

P10: 45
P20: 45
P40: 45
P60: 45
P80: 45
P90: 47

```

#### Grok

- ok=False | t_ms=169 | tokens: prompt=0, completion=0, total=0 | cost=$0.000000

- error=HTTP 429: Your team 0101076a-72f1-4f25-a038-b346d74bbc8d has either used all available credits or reached its monthly spending limit. To continue making API requests, please purchase more credits or raise your spending limit.

### Aggregation (BMC)

- final_quantiles: P10=-797.760124704511, P50=515.9441716026629, P90=2419.129880173401

- bmc_summary={"mean": 680.8380872678931, "p10": -797.760124704511, "p50": 515.9441716026629, "p90": 2419.129880173401}